Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | G6PD | P11413 | 1/20 | 0.63 |
| ▸ | CASP7 | P55210 | 1/20 | 0.63 |
| ▸ | CASP6 | P55212 | 1/20 | 0.63 |
| ▸ | MMP2 | P08253 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.45 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.43 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.43 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.43 |
| ▸ | METAP2 | P50579 | 1/20 | 0.43 |
| ▸ | IKBKB | O14920 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL526919 | 0.91 | G6PD (0.74) | G6PDCASP7CASP6MMP2ALDH1A1 | |
| SCHEMBL40536 | 0.91 | ALDH1A1 (0.54) | G6PDCASP7CASP6MMP2ALDH1A1 | |
| SCHEMBL28281319 | 0.88 | G6PD (0.71) | G6PDCASP7CASP6MMP2ALDH1A1 | |
| SCHEMBL30806223 | 0.88 | G6PD (0.71) | G6PDCASP7CASP6MMP2ALDH1A1 | |
| Methoxymethane SCHEMBL5903652 | 0.82 | G6PD (0.63) | G6PDCASP7CASP6MMP2ALDH1A1 | |
| Carbamic Acid SCHEMBL5529842 | 0.80 | G6PD (0.61) | G6PDCASP7CASP6MMP2ALDH1A1 | |
| SCHEMBL6999515 | 0.80 | KDM4E (0.45) | G6PDCASP7CASP6ALDH1A1BCAT2 | |
| SCHEMBL623198 | 0.80 | ALDH1A1 (0.45) | G6PDCASP7CASP6MMP2ALDH1A1 | |
| SCHEMBL2489109 | 0.80 | G6PD (0.61) | G6PDCASP7CASP6MMP2ALDH1A1 | |
| SCHEMBL5807536 | 0.79 | MAPT (0.60) | ALDH1A1BCAT2KDM4EHPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080032409-A1 | FLUORESCENT BIOMOLECULE LABELING REAGENTS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2008-02-07 | — | — | US | disclosed |
| US-20080032409-A1 | FLUORESCENT BIOMOLECULE LABELING REAGENTS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2008-02-07 | — | — | US | disclosed |
| EP-0781767-B1 | Process for producing isatoic anhydrides | SUMITOMO CHEMICAL CO (JP) | 2001-09-05 | — | — | EP | disclosed |
| WO-2000069943-A1 | POLYUREA COMPOSITION | K & L TECHNOLOGIES, INC. (US) | 2000-11-23 | — | — | WO | disclosed |
| US-5981749-A | Process for producing isatoic anhydrides | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1999-11-09 | — | — | US | disclosed |
| US-5973145-A | Process for producing isatoic anhydrides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-10-26 | — | — | US | disclosed |
| EP-0781767-A1 | Process for producing isatoic anhydrides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1997-07-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080032409-A1 | FLUORESCENT BIOMOLECULE LABELING REAGENTS | PAICS, IPMK, IK | G6PD 3214/4885CASP7 4405/4885CASP6 4178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.